A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: A Canadian multicenter study
- 31 January 1997
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 99 (1), 13-21
- https://doi.org/10.1016/s0091-6749(97)70295-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Regular vs as-needed inhaled salbutamol in asthma controlThe Lancet, 1994
- Long- Versus Short-Acting ??2-AgonistsDrugs, 1994
- The effect of salmeterol on the early‐ and late‐phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein XAllergy, 1993
- Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.Thorax, 1993
- Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthmaJournal of Allergy and Clinical Immunology, 1992
- The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hoursJournal of Allergy and Clinical Immunology, 1992
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.BMJ, 1990
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988